Compounds > azacitidine

azacitidine and Autosomal Chromosome Disorders

azacitidine has been researched along with Autosomal Chromosome Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Angelopoulou, MK; Chatzidimitriou, C; Konstantopoulos, K; Korkolopoulou, P; Lafioniatis, S; Lakiotaki, E; Pappa, V; Plata, E; Vassilakopoulos, TP1
Golomb, HM; Larson, RA; Rowley, JD; Sweet, DL; Testa, JR1
Anisowicz, A; Gadi, IK; Harrison, JJ; Raffeld, M; Sager, R1
Gadi, IK; Harrison, JJ; Sager, R1
Ehrlich, M; Frady, A; Hernandez, R; Ji, W; Qu, GZ; Varela, M; Zhang, XY1
Andre, M; Bosly, A; Ferrant, A; Kunzmann, R; Lübbert, M; Ravoet, C; Verhoef, G; Wijermans, P1
Abella, E; Alvarado, CS; Chauvenet, A; Dubowy, R; Harris, M; Inoue, S; Krischer, JP; Ravindranath, Y; Ritchey, AK; Wiley, J1

Other Studies

7 other study(ies) available for azacitidine and Autosomal Chromosome Disorders

ArticleYear
Pancytopenia, eosinophilia and coagulation disorders in a patient with T-acute lymphoblastic leukemia in prolonged remission.
    American journal of hematology, 2021, 05-01, Volume: 96, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers, Tumor; Blood Cell Count; Bone Marrow; Cancer Survivors; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Diagnosis, Differential; Eosinophilia; Hemorrhagic Disorders; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Mastocytosis, Systemic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pancytopenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Staurosporine; Tryptases

2021
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings.
    Cancer, 1982, Jun-01, Volume: 49, Issue:11

    Topics: Adult; Azacitidine; Bone Marrow; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, 21-22 and Y; Chromosomes, Human, 6-12 and X; Female; Follow-Up Studies; Humans; Karyotyping; Leukemia, Lymphoid; Male; Middle Aged; Translocation, Genetic

1982
Azacytidine-induced tumorigenesis of CHEF/18 cells: correlated DNA methylation and chromosome changes.
    Proceedings of the National Academy of Sciences of the United States of America, 1983, Volume: 80, Issue:21

    Topics: Adipose Tissue; Animals; Azacitidine; Cell Line; Chromosome Aberrations; Chromosome Disorders; Cricetinae; DNA, Neoplasm; Karyotyping; Methylation; Mice; Mice, Nude; Neoplasms, Experimental; Trisomy

1983
Genetic analysis of tumorigenesis: XVI. Chromosome changes in azacytidine- and insulin-induced tumorigenesis.
    Somatic cell and molecular genetics, 1984, Volume: 10, Issue:5

    Topics: Animals; Azacitidine; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosome Banding; Chromosome Disorders; Cricetinae; Cricetulus; Embryo, Mammalian; Insulin; Karyotyping; Neoplasms, Experimental

1984
DNA demethylation and pericentromeric rearrangements of chromosome 1.
    Mutation research, 1997, Sep-05, Volume: 379, Issue:1

    Topics: Adult; Azacitidine; B-Lymphocytes; Burkitt Lymphoma; Cell Line; Cell Line, Transformed; Centromere; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 1; Decitabine; DNA Methylation; DNA, Satellite; Face; Fibroblasts; Heterochromatin; Humans; Immunologic Deficiency Syndromes; Male; Stem Cells; Tumor Cells, Cultured

1997
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
    British journal of haematology, 2001, Volume: 114, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Antimetabolites, Antineoplastic; Azacitidine; Chromosome Aberrations; Chromosome Disorders; Decitabine; Drug Administration Schedule; Female; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Risk; Survival Rate

2001
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.
    Blood, 1992, Nov-01, Volume: 80, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azacitidine; Child; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Thioguanine; Vincristine

1992